↓ Skip to main content

American Association for Cancer Research

Optimization of antibody binding to FcγRIIa enhances macrophage phagocytosis of tumor cells

Overview of attention for article published in Molecular Cancer Therapeutics, August 2008
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (90th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

patent
146 patents

Citations

dimensions_citation
257 Dimensions

Readers on

mendeley
266 Mendeley
Title
Optimization of antibody binding to FcγRIIa enhances macrophage phagocytosis of tumor cells
Published in
Molecular Cancer Therapeutics, August 2008
DOI 10.1158/1535-7163.mct-08-0201
Pubmed ID
Authors

John O. Richards, Sher Karki, Greg A. Lazar, Hsing Chen, Wei Dang, John R. Desjarlais

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 266 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 1%
Germany 1 <1%
Belgium 1 <1%
Australia 1 <1%
Unknown 260 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 87 33%
Student > Ph. D. Student 44 17%
Student > Master 20 8%
Other 17 6%
Student > Bachelor 15 6%
Other 27 10%
Unknown 56 21%
Readers by discipline Count As %
Agricultural and Biological Sciences 86 32%
Biochemistry, Genetics and Molecular Biology 37 14%
Immunology and Microbiology 25 9%
Medicine and Dentistry 16 6%
Pharmacology, Toxicology and Pharmaceutical Science 8 3%
Other 34 13%
Unknown 60 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 March 2024.
All research outputs
#2,570,445
of 23,549,388 outputs
Outputs from Molecular Cancer Therapeutics
#316
of 3,920 outputs
Outputs of similar age
#7,236
of 84,757 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#4
of 81 outputs
Altmetric has tracked 23,549,388 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,920 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.5. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 84,757 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 81 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.